-
-
-
-
-
-
-
H.C. Wainwright Downgrades Arcturus Therapeutics (ARCT) to Neutral
-
-
-
-
-
-
-
Form SCHEDULE 13G/A Arcturus Therapeutics Filed by: ARK Investment Management LLC
-
-
-
-
-
-
-
Arcturus Therapeutics (ARCT) Misses Q1 EPS by 411c
-
-
-
-
-
-
-
BTIG Reiterates Buy Rating on Arcturus Therapeutics (ARCT)
-
-
-
-
-
-
-
BTIG Starts Arcturus Therapeutics (ARCT) at Buy
-
-
-
-
-
-
-
Canaccord Genuity Reiterates Buy Rating on Arcturus Therapeutics (ARCT)
-
-
-
-
-
-
-
Laidlaw Reiterates Buy Rating on Arcturus Therapeutics (ARCT)
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

